Guardion Health Sciences, Inc.

OTCPK:GHSI Stock Report

Market Cap: US$4.3m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Guardion Health Sciences Management

Management criteria checks 2/4

Guardion Health Sciences' CEO is Mark Goldstone, appointed in Oct 2024, has a tenure of less than a year. directly owns 0.26% of the company’s shares, worth $11.27K. The average tenure of the management team and the board of directors is 1.3 years and 7.5 years respectively.

Key information

Mark Goldstone

Chief executive officer

US$75.1k

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownership0.3%
Management average tenure1.3yrs
Board average tenure7.5yrs

Recent management updates

Recent updates

Take Care Before Jumping Onto Guardion Health Sciences, Inc. (NASDAQ:GHSI) Even Though It's 39% Cheaper

Sep 22
Take Care Before Jumping Onto Guardion Health Sciences, Inc. (NASDAQ:GHSI) Even Though It's 39% Cheaper

Market Might Still Lack Some Conviction On Guardion Health Sciences, Inc. (NASDAQ:GHSI) Even After 26% Share Price Boost

Jun 06
Market Might Still Lack Some Conviction On Guardion Health Sciences, Inc. (NASDAQ:GHSI) Even After 26% Share Price Boost

Why Guardion Health Sciences, Inc. (NASDAQ:GHSI) Could Be Worth Watching

Apr 10
Why Guardion Health Sciences, Inc. (NASDAQ:GHSI) Could Be Worth Watching

Guardion Health Sciences, Inc. (NASDAQ:GHSI) Soars 46% But It's A Story Of Risk Vs Reward

Feb 06
Guardion Health Sciences, Inc. (NASDAQ:GHSI) Soars 46% But It's A Story Of Risk Vs Reward

Market Cool On Guardion Health Sciences, Inc.'s (NASDAQ:GHSI) Revenues

Apr 17
Market Cool On Guardion Health Sciences, Inc.'s (NASDAQ:GHSI) Revenues

Guardion Health Sciences GAAP EPS of -$0.03 beats by $0.01, revenue of $3.27M beats by $0.67M

Aug 11

Guardion Health closes Activ Nutritional acquisition

Jun 02

Guardion Health initiates GlaucoCetin glaucoma trial

May 03

The Guardion Health Sciences (NASDAQ:GHSI) Share Price Has Gained 90% And Shareholders Are Hoping For More

Jan 15
The Guardion Health Sciences (NASDAQ:GHSI) Share Price Has Gained 90% And Shareholders Are Hoping For More

Guardion Health names industry veteran Bret Scholtes as new president and CEO

Dec 28

Is Guardion Health Sciences (NASDAQ:GHSI) In A Good Position To Invest In Growth?

Nov 24
Is Guardion Health Sciences (NASDAQ:GHSI) In A Good Position To Invest In Growth?

CEO

Mark Goldstone (60 yo)

less than a year

Tenure

US$75,099

Compensation

Mr. Mark Goldstone has been Interim President, Chief Executive Officer and Director of Guardion Health Sciences Inc. since October 18, 2024. He serves as a Partner at Eckuity. He serves as Senior Partner a...


Leadership Team

NamePositionTenureCompensationOwnership
Robert Weingarten
Independent Chairman & Secretary9.4yrsUS$112.60k0.51%
$ 22.1k
Mark Goldstone
Interim Presidentless than a yearUS$75.10k0.26%
$ 11.3k
Katie Cox
Chief Accounting Officer1.3yrsUS$275.00kno data

1.3yrs

Average Tenure

60yo

Average Age

Experienced Management: GHSI's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Robert Weingarten
Independent Chairman & Secretary9.4yrsUS$112.60k0.51%
$ 22.1k
Mark Goldstone
Interim President9.4yrsUS$75.10k0.26%
$ 11.3k
Donald Gagliano
Independent Director5.6yrsUS$27.60k0.041%
$ 1.8k
Michaela Griggs
Independent Director2.9yrsUS$27.60k0%
$ 0

7.5yrs

Average Tenure

65.5yo

Average Age

Experienced Board: GHSI's board of directors are considered experienced (7.5 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/11/01 05:40
End of Day Share Price 2024/10/30 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Guardion Health Sciences, Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Edward WooAscendiant Capital Markets LLC
Anthony VendettiMaxim Group